Timothy Blackwell
Pulmonary Disease · Ann Arbor, MINPI 1649379074
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $81,156 of the $98,693 with a category attached, or 82.2%. Boehringer Ingelheim accounts for 67.8% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2020 at $30,905 and has fallen 62.2% since, to $11,682 in 2025. Among pulmonary disease clinicians in MI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 50 payments — averaging $1973.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boehringer Ingelheim$67K
- Boehringer Ingelheim International GmbH$18K
- Janssen Research & Development, LLC$5K
- Sage Therapeutics, LLC$4K
- E.r. Squibb & Sons, L.L.C.$3K
- Partner Therapeutics, Inc.$2K
- plus $251 from 4 others
Across 8 payments — averaging $303,317 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Boehringer Ingelheim$1.1M
- Boehringer Ingelheim International GmbH$1M
- E.r. Squibb & Sons, L.L.C.$191K
- Bristol Myers Squibb$106K
What the payments were for
- Consulting fees$81,15682%
- Travel & lodging$16,25916%
- Food & beverage$1,2781%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boehringer Ingelheim | 27 | $66,895 |
| Boehringer Ingelheim International GmbH | 9 | $18,004 |
| Janssen Research & Development, LLC | 3 | $5,250 |
| Sage Therapeutics, LLC | 2 | $3,625 |
| E.r. Squibb & Sons, L.L.C. | 1 | $2,643 |
| Partner Therapeutics, Inc. | 2 | $2,025 |
| Genentech USA, Inc. | 1 | $125 |
| Bristol Myers Squibb | 1 | $56 |
| Incyte Corporation | 3 | $50 |
| Johnson & Johnson | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$98,693 in reported general payments places this provider in the 95th percentile of 463 pulmonary disease providers in Michigan.
Other pulmonary disease in Ann Arbor
- Meilan HanAnn Arbor$779K
- Njira LugogoAnn Arbor$741K
- Justin OldhamAnn Arbor$392K
- Kevin FlahertyAnn Arbor$328K
- Jose de CardenasAnn Arbor$115K
- Philip ChoiAnn Arbor$54K
- Jeanette BrownAnn Arbor$38K
- Jeffrey CurtisAnn Arbor$37K
- Vibha LamaAnn Arbor$26K
- Eric WhiteAnn Arbor$23K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.